Treatment retention on fingolimod compared with injectable multiple sclerosis therapies in African-American patients: A subgroup analysis of a randomized phase 4 study
Keywords: AE; adverse event; ANCOVA; analysis of covariance; ARR; annualized relapse rate; CI; confidence interval; EDSS; Expanded Disability Status Scale; Gd+; gadolinium-enhancing; iDMT; injectable disease-modifying therapy; MRI; magnetic resonance imaging; MS; m